Novel mutations and role of the LKB1 gene as a tumor suppressor in renal cell carcinoma

Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy

(2014) M. H. Voss et al.   CLINICAL CANCER RESEARCH

Seeing the Forest for the Trees: Kidney Oncogenomes in Relation to Therapeutic Outcomes

(2014) D. D. Chism et al.   CLINICAL CANCER RESEARCH

Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo

(2013) W C Duivenvoorden et al.   BRITISH JOURNAL OF CANCER

Comprehensive molecular characterization of clear cell renal cell carcinoma

(2013)   NATURE

Integrated molecular analysis of clear-cell renal cell carcinoma

(2013) Yusuke Sato et al.   NATURE GENETICS

LKB1 mutations and their correlation with LKB1 and Rheb expression in bladder cancer

(2012) Hatice Tigli et al.   MOLECULAR CARCINOGENESIS

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

(2012) Marco Gerlinger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer

(2011) Aymen A Elfiky et al.   Journal of Translational Medicine

Genetic Alterations of the LKB1 Gene in Head and Neck Cancer

(2010) Ebru Kenanli et al.   DNA AND CELL BIOLOGY

Localization-specific LKB1 loss in head and neck squamous cell carcinoma metastasis

(2010) Erik R. Kline et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

VHL and HIF signalling in renal cell carcinogenesis

(2010) Marcella M Baldewijns et al.   JOURNAL OF PATHOLOGY

LKB1 Regulates Pancreatic β Cell Size, Polarity, and Function

(2009) Zvi Granot et al.   Cell Metabolism